Table 2

Variants of uncertain significance in known and candidate BAVM genes

Patient Inheritance Zygosity Chr Position Mutation type Gene symbol Ref transcript Variant nomenclature VR/TR ExAC AF-East Asian ExAC AF-total 
AVM403MaternalHet1252308249Missense ACVRL1 NM_001077401.1c.652 C > T (p.Arg218Trp)46/810.00170.00036
AVM375MaternalHet1252309874Missense ACVRL1 NM_001077401.1c.1103C>T(p.Pro368Leu)41/7600.0000083
AVM285PaternalHet586564378Missense RASA1 NM_002890.2c.110A>G(p.Lys37Arg)23/5300
AVM519PaternalHet586564492Missense RASA1 NM_002890.2c.224G>C(p.Gly75Ala)48/990.00740.00058
AVM515PaternalHet586564614Missense RASA1 NM_002890.2c.346C>T(p.Leu116Phe)112/11700
AVM132PaternalHet586649000Missense RASA1 NM_002890.2c.1280G>A(p.Arg427Gln)27/470.000120.000033
AVM028PaternalHet586672720Missense RASA1 NM_002890.2c.2207A>G(p.His736Arg)77/16000
AVM578PaternalHet586685291Missense RASA1 NM_002890.2c.2476G>A(p.Val826Met)39/670.000230.000033
AVM359MaternalHet9130588074Missense ENG NM_000118.3c.589C>T(p.Arg197Trp)18/4100.000041
AVM511MaternalHet2203395591Missense BMPR2 NM_001204.6c.1042G>A(p.Val348Ile)17/360.00640.00045
Patients*PaternalHet2203417506Missense BMPR2 NM_001204.6c.1481C>T(p.Ala494Val)23/55 19/380.000580.000041
AVM235PaternalHet2203421066Missense BMPR2 NM_001204.6c.2678G>A(p.Arg893Gln)47/9400.0000082
Patients†ComhetHet11117301521Missense  DSCAML1  NM_031220.3 c.5783G>A(p.Arg1928His) 59/111; 46/106  0.00370.00028 
Patients†ComhetHet11117308649Missense DSCAML1 NM _031220.3c.4574 G > A (p.Arg1525His)35/72; 25/560.00130.00013
AVM226ComhetHet2141465723 Missense  DSCAM  NM_001389.3 c.3775G>A(p.Val1259Ile) 41/85 0.0038 0.00032 
AVM226ComhetHet2141539197Missense DSCAM NM _001389.3c.2966 A > T (p.Gln989Leu)37/7100
AVM144ComhetHet 87593517 Splice acceptor  PTPN13  NM_006264.2 c.116‐1G>A 39/99 00
AVM144ComhetHet487622759Missense PTPN13 NM_006264.2c.1000 T > A (p.Ser334Thr)68/1370.000350.000025
  • *Recurrent in AVM199 and AVM401.

  • †Recurrent in AVM106 and AVM285.

  • AF, allele frequency; BAVM, brain arteriovenous malformation; Het, heterozygous; Chr, chromosome; Comhet, compound heterozygous; ExAC, Exome Aggregation Consortium; Het, heterozygous; pLI, probability of loss-of-function intolerance; Ref, reference; VR/TR,variant reads/total reads.